Dynavax Technologies Corp (DVAX)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

2100 POWELL STREET EMERYVILLE, CA 94608

Discovers, develops and intends to commercialize innovative products to treat and prevent allergies, infectious diseases and chronic inflammatory diseases using proprietary approaches that alter immune system responses. Its clinical development programs are based on immunostimulatory sequences.

Data as of 2021-05-08 10:36:23 -0400
Market Cap1.124 Billion Shares Outstanding114.588 Million Avg 30-day Volume2.654 Million
P/E Ratio-14.94033 Dividend Yield EPS-0.741
Price/Sales24.15 Debt to Equity6.02 EBITDA-68.387 Million
Price to Book Value19.15 Forward PE16.7 Enterprise Value1.139 Billion
Total Cash165.036 Million Current Debt77.411 Million Gross Profit32.641 Million
BETA1.39945 52-week High/Low12.44 / 3.55 Next Earnings Date2021-08-05 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from DVAX instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 2 2 0.0% 1 (0.06%) 1 (0.06%) 0.0%
Funds Holding: 142 163 -12.88% 32 (1.92%) 46 (2.86%) -30.43%
13F shares: 84.103 Million 88.06 Million -4.49% 14.161 Million 19.627 Million -27.85%
% Ownership 76.3369 79.9294 -4.49% 12.8536 17.8145 -27.85%
New Positions: 11 43 -74.42% 4 18 -77.78%
Increased Positions 53 49 8.16% 10 12 -16.67%
Closed Positions 31 26 19.23% 18 15 20.0%
Reduced Positions 43 40 7.5% 14 12 16.67%
Total Calls 661.73 Thousand 1.052 Million -37.07% 140.8 Thousand 300.4 Thousand -53.13%
Total Puts 800.924 Thousand 857.767 Thousand -6.63% 74.7 Thousand 92.5 Thousand -19.24%
PUT/CALL Ratio 1.21 0.82 47.56% 0.53 0.31 70.97%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding DVAX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding DVAX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

20 Thousand total shares from 1 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

NOVACK DAVID F PRESIDENT & COO

  • Officer
117,399 2021-04-01 2

JANSSEN ROBERT SENIOR VICE PRESIDENT

  • Officer
86,861 2021-03-12 5

MACDONALD KELLY SVP AND CFO

  • Officer
0 2021-03-01 2

BURGESS JUSTIN PRINCIPAL ACCOUNTING OFFICER

  • Officer
33,718 2021-02-26 3

SPENCER RYAN CEO AND DIRECTOR

  • Officer
  • Director
90,453 2021-02-22 2

OSTRACH MICHAEL S SENIOR VICE PRESIDENT

  • Officer
0 2021-02-03 1

PARADISO PETER R.

  • Director
0 2020-09-23 2

EASTLAND JULIA MARIE

  • Director
0 2020-07-17 2

MACGREGOR BRENT

  • Director
0 2020-07-17 2

PHILLIPS PEGGY V

  • Director
0 2020-05-28 1

ORONSKY ARNOLD L

  • Director
0 2020-05-28 1

CANO FRANCIS

  • Director
0 2020-05-28 1

KISNER DANIEL L

  • Director
0 2020-05-28 1

RICCIARDI NATALE S

  • Director
0 2020-05-28 1

HACK ANDREW A. F.

  • Director
0 2020-05-28 2

JOHNSON DAVID LOUIS VICE PRESIDENT

  • Officer
48,380 2020-03-13 0

COFFMAN ROBERT SENIOR VICE PRESIDENT

  • Officer
77,768 2019-06-02 0

GRAY EDDIE CEO AND DIRECTOR

  • Officer
  • Director
304,597 2019-06-02 0

CARSON DENNIS

  • Director
0 2019-05-30 0

BREGE LAURA

  • Director
0 2019-05-30 0

PLOTKIN STANLEY A

  • Director
0 2017-06-02 0

DINA DINO

  • Director
0 2014-05-28 0

GILBERT DENISE

  • Director
0 2014-05-28 0

LEW JENNIFER VP, FINANCE & PAO

  • Officer
0 2013-02-05 0

TUCK STEPHEN F VP, GLOBAL TECHNICAL OPS

  • Officer
0 2013-02-05 0

MARTIN J TYLER PRESIDENT, CMO & DIRECTOR

  • Officer
  • Director
222,089 2012-11-16 0

KESSEL MARK

  • Director
3,031,431 2012-10-16 0

LARSON CHRISTINE R VP AND CHIEF FINANCIAL OFFICER

  • Officer
0 2012-08-13 0

JANOWICZ ZBIGNIEW CEO DYNAVAX EUROPE

  • Officer
0 2012-03-09 0

BUC NANCY L

  • Director
0 2010-05-12 0

LAWRENCE DAVID M

  • Director
0 2010-05-12 0

SYMPHONY CAPITAL PARTNERS LP

SYMPHONY CAPITAL GP, L.P.

SYMPHONY GP, LLC

SYMPHONY STRATEGIC PARTNERS LLC

TARANTO HARRI V

  • Director
  • 10% Owner
  • SEE FOOTNOTE 5 AND REMARKSSEE FOOTNOTE 5 AND REMARKSSEE FOOTNOTE 5 AND REMARKSSEE FOOTNOTE 5 AND REMARKSSEE FOOTNOTE 5 AND REMARKS
9,031,431 2010-04-16 0

BVF PARTNERS L P/IL

BIOTECHNOLOGY VALUE FUND L P

BIOTECHNOLOGY VALUE FUND II LP

BVF INVESTMENTS LLC

LAMPERT MARK N

BVF INC/IL

  • 10% Owner
  • DIRECT BENEFICIAL OWNERDIRECT BENEFICIAL OWNERDIRECT BENEFICIAL OWNER
17,115,404 2009-09-10 0

BVF PARTNERS L P/IL

BIOTECHNOLOGY VALUE FUND L P

BIOTECHNOLOGY VALUE FUND II LP

BVF INVESTMENTS LLC

BVF INC/IL

  • 10% Owner
  • INDIRECT BENEFICIAL OWNERDIRECT BENEFICIAL OWNERDIRECT BENEFICIAL OWNERDIRECT BENEFICIAL OWNERINDIRECT BENEFICIAL OWNER
25,254,628 2009-06-03 0

SMELTZER DEBORAH A VP, OPERATIONS & CFO

  • Officer
0 2009-03-10 0

FLYNN JAMES E

DEERFIELD CAPITAL LP

DEERFIELD SPECIAL SITUATIONS FUND, L.P.

DEERFIELD MANAGEMENT CO /NY

DEERFIELD SPECIAL SITUATIONS FUND INTERNATIONAL LTD

DEERFIELD PRIVATE DESIGAN FUND L P

DEERFIELD PRIVATE DESIGN INTERNATIONAL, L.P.

  • 10% Owner
No longer subject to file 2008-10-22 0

SANDERS MARTIN E EVP AND CDO

  • Officer
0 2008-10-03 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

NOVACK DAVID F - Officer PRESIDENT & COO

2021-04-02 18:00:55 -0400 2021-04-01 S 20,000 $9.92 d 117,399 direct 2.8455 2.3374 2.8455 2 0.0 1

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
RUSSELL INVESTMENT CO- U.S. Small Cap Equity Fund DVAX -10953.0 shares, $-40854.69 2020-10-31 N-PORT
RUSSELL INVESTMENT FUNDS- U.S. Small Cap Equity Fund DVAX -1540.0 shares, $-6853.0 2020-12-31 N-PORT
LoCorr Investment Trust- LoCorr Dynamic Equity Fund DVAX -4009.0 shares, $-17840.05 2020-12-31 N-PORT
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund DVAX -30.0 shares, $-294.9 2021-03-31 N-PORT

Elevate your investments